The market is segmented based on , By Type (Troponin I and T, Creatine kinase-MB (CK-MB), Brain Natriuretic peptide (Bnp or Nt-Probnp), Myoglobin, HIGH-sensitivity C-reactive protein (hs-CRP), and Other Biomarkers), Product (Instruments, Chemiluminescence, Immunofluorescence, ELISA, Immunochromatography, Reagents and Kits), Disease (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Ischemia), Type of Testing (Laboratory Testing, Academic Institutions, and Point-Of-Care Testing) – Industry Trends and Forecast to 2031.
.
The Global Cardiac Marker Testing Market size was valued at USD 12.68 USD Billion in 2023.
The Global Cardiac Marker Testing Market is projected to grow at a CAGR of 9.1% during the forecast period of 2024 to 2031.
The major players operating in the market include F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Siemens (Germany), Danaher (U.S.), bioMérieux, Inc. (France), Ortho Clinical Diagnostics (U.S.), Randox Laboratories Ltd (U.K.), BG Medicine (U.S.), HUMAN Co (Germany), Bhat Bio-tech India Private Limited (India),Merck KGaA (Germany), PerkinElmer Inc. (U.S.), QIAGEN (Netherlands), Agilent Technologies, Inc. (U.S.), Bruker (U.S.), Epigenomics AG (Germany), MESO SCALE, DIAGNOSTICS, LLC (U.S.), EKF Diagnostics Holdings plc. (U.K.), Nexus-Dx (U.S.), LifeSign LLC. (U.S.), DIALAB GmbH (Austria), Beckman Coulter, Inc. (U.S.).
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East and Africa.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.